SCHEMBL7415839

SCHEMBL7415839

COc1ccc(S(=O)(=O)NC(CNS(=O)(=O)c2ccc(C(C)(C)C)cc2)C(=O)NO)cc1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP7 P09237 5/20 0.66
MMP9 P14780 3/20 0.66
MMP10 P09238 1/20 0.66
ALDH1A1 P00352 1/20 0.48
MAPT P10636 1/20 0.48
MEP1B Q16820 1/20 0.48
BMP1 P13497 8/20 0.48
MMP13 P45452 2/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
MMP1 P03956 1/20 0.47
MMP2 P08253 1/20 0.47
MMP8 P22894 1/20 0.47
HDAC3 O15379 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7414877 1.00 MMP7 (0.66) MMP7MMP9MMP10ALDH1A1MAPT
SCHEMBL7419489 0.92 MMP7 (0.77) MMP7MMP9MMP10ALDH1A1MAPT
SCHEMBL7417246 0.92 MMP7 (0.65) MMP7MMP9MMP10ALDH1A1MEP1B
SCHEMBL7419926 0.87 MMP7 (0.60) MMP7MMP9MMP10ALDH1A1MAPT
SCHEMBL7414393 0.87 MMP7 (0.70) MMP7MMP9MMP10ALDH1A1MAPT
SCHEMBL7417827 0.86 MMP7 (0.59) MMP7MMP9MMP10MEP1BBMP1
SCHEMBL7411340 0.86 MMP7 (0.59) MMP7MMP9MMP10MEP1BBMP1
SCHEMBL7417364 0.86 MMP7 (0.69) MMP7MMP9MMP10ALDH1A1MAPT
SCHEMBL7417547 0.86 MMP7 (0.69) MMP7MMP9MMP10ALDH1A1MAPT
SCHEMBL7423461 0.83 MMP7 (0.58) MMP7MMP9MMP10ALDH1A1MEP1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed